Apple’s very public dispute with health device maker Masimo has got tongues wagging over the possibility of the Apple Watch – one of the best smartwatches in the world – being banned in the US. As a result, Apple has had to disable blood oxygen monitoring features on its devices – and that could have serious implications for other planned features.
As Bloomberg journalist Mark Gurman notes in his latest Power On newsletter, sleep apnea tracking – a key feature that’s rumored to be coming to the next Apple Watch later this year – might be at risk.
Why? Well, Apple’s conflict with Masimo all comes down to patents Masimo holds regarding blood oxygen monitoring. Apple has recently been ruled to be in violation of those patents, and the company was forced to implement a software fix that disabled the feature in any new Watches it sold.
Gurman believes that being able to keep track of blood oxygen is vital for sleep apnea monitoring, and that if Apple is barred from implementing any kind of blood oxygen feature in its wearables, that would have a knock-on effect on its sleep apnea plans, and potentially other upcoming new features as well if they also rely on checking blood oxygen levels.